Mirtazapine Tablets, USP 15mg, 30-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 13107-031-34
Published April 22, 2020 · Recall initiated: March 18, 2020
Summary
FDA records drug Class II recall D-1235-2020, published April 22, 2020 and initiated March 18, 2020. Recalling firm: Aurobindo Pharma USA Inc.; Status: Terminated; Reported quantity: 56208 units; Lot: Lot #: 031180028A, Exp. Date 03/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
What to do
Voluntary: Firm initiated · Letter
Get an email if MIRTAZAPINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- MIRTAZAPINE
- Manufacturer
- Aurobindo Pharma USA Inc.
- Distributor
- Nationwide within the United States
- Lot
- Lot #: 031180028A, Exp. Date 03/2021
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASimvastatin Tablets, USP 40mg 90-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJApril 22, 2020
- FDAPhentermine Hydrochloride Capsules, USP 15mg, 100-count bottles, Distributed by: Aurobindo Phama USA, Inc.April 22, 2020
- FDALevetiracetam Tablets USP 750 mg 120-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279April 22, 2020
- FDAMirtazapine Tablets, USP, 15 mg, 500-count tablets, Rx only, Distributed by: Aurobindo Pharma USA, Inc.December 18, 2019
- FDAMirtazapine Tablets, USP 45 mg, a) 30 count, b) 100 count and c) 500 count bottles, Rx only, MylanMarch 15, 2017
- FDAMirtazapine Tablets, USP, 45 mg. Rx only, 100 Tablets (10 X 10). Manufactured by: Mylan Pharmaceuticals Inc,March 15, 2017
Questions about this recall
Was Mirtazapine Tablets, USP 15mg, 30-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 13107-031-34 recalled?
Yes. FDA published recall D-1235-2020 on April 22, 2020. Reported hazard: CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: MIRTAZAPINE.